Table 3 Clinical features of three patients who achieved triple response
Number | age (years)/sex | genotype | Pretreatment HBV titer (log copies/mL) | Pretreatment HBsAg titer (IU/ml) | HBeAg | Dose of PEG-IFN (μg) | Duration of PEG-IFN treatment (weeks) | Pretreatment AST/ALT (IU/ml) |
|---|---|---|---|---|---|---|---|---|
1 | 26/male | C | 7.6 | 4470 | positive | 180 | 48 | 47/123 |
2 | 30/female | C | 5.3 | 1000 | positive | 90 | 48 | 45/62 |
3 | 34/male | A | 7.6 | 881 | positive | 90 | 48 | 37/397 |